Cardiac Biomarkers Global Market Report 2024

Description

“Cardiac Biomarkers Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac biomarkers? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The cardiac biomarkers market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Biomarkers Type: Creatine Kinase (CK-Mb); Troponins; Myoglobin; Natriuretic Peptides (BNP And NT-proBNP); Ischemia Modified Albumin (IMA); Other Biomarker Types
2) By Location Of Testing: Point Of Care Testing; Laboratory Testing
3) By Application: Myocardial Infarction; Congestive Heart Failure; Acute Coronary Syndrome (ACS); Atherosclerosis; Other Applications
4) By End User: Hospitals; Specialty Clinics
Companies Mentioned: bioMerieux Inc.; Bio-Rad Laboratories; F. Hoffmann-La Roche AG; Siemens AG; Thermo Fisher Scientific Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Cardiac biomarkers represent substances released by the heart into the bloodstream during periods of injury or stress, aiding in the detection and measurement of various cardiac and vascular conditions.

The primary categories of cardiac biomarkers encompass creatine kinase (CK-MB), troponins, myoglobin, natriuretic peptides (BNP and NT-proBNP), ischemia-modified albumin (IMA), among others. Creatine kinase (CK) is an enzyme present in multiple body tissues, including muscles and the brain, commonly utilized in diagnosing myocardial infarction (MI), commonly known as a heart attack. These biomarkers find application across diverse testing settings such as point-of-care and laboratory-based assessments. They serve multiple diagnostic purposes, including testing for myocardial infarction, congestive heart failure, acute coronary syndrome (ACS), atherosclerosis, among other cardiac conditions. Hospitals and specialized clinics heavily rely on these biomarkers in their diagnostic protocols.

The cardiac biomarkers market research report is one of a series of new reports from The Business Research Company that provides cardiac biomarkers market statistics, including cardiac biomarkers industry global market size, regional shares, competitors with a cardiac biomarkers market share, detailed cardiac biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac biomarkers industry. This cardiac biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac biomarkers market size has grown rapidly in recent years. It will grow from $17.22 billion in 2023 to $19.48 billion in 2024 at a compound annual growth rate (CAGR) of 13.1%. The growth observed in the past period can be traced back to several key factors. These include a notable rise in healthcare expenditure, the facilitation of FDA approvals and regulatory support, demographic shifts toward an aging population, extensive awareness programs, advancements in high-sensitivity troponin tests, and a concurrent increase in the prevalence of cardiovascular diseases. These factors collectively contributed to the growth experienced during that timeframe in the realm of cardiac biomarkers and related diagnostics.

The cardiac biomarkers market size is expected to see rapid growth in the next few years. It will grow to $31.88 billion in 2028 at a compound annual growth rate (CAGR) of 13.1%. The anticipated growth in the forthcoming period is poised to result from several driving forces. These encompass the escalating burden of chronic diseases, an increased emphasis on early disease detection initiatives, the continual expansion of the geriatric population, ongoing development in emerging markets, and a heightened focus on the utilization of biomarker panels.

The anticipated surge in cardiac biomarker market growth is closely linked to the increasing prevalence of cardiovascular disorders. These ailments encompass a range of heart and blood vessel conditions, including coronary artery disease, heart failure, and strokes. Cardiac biomarkers, released into the bloodstream due to specific cardiovascular disorders such as heart attacks, heart failure, and arrhythmias, offer vital diagnostic and prognostic information when measured via laboratory tests. For instance, the Centers for Disease Control and Prevention reported that in 2021, coronary artery disease (CAD) claimed 375,476 lives, affecting approximately 1 in 20 adults aged 20 and older. Alarmingly, about 2 in 10 CAD-related deaths occur in individuals under 65 years old. Hence, the escalating prevalence of cardiovascular disorders significantly fuels the growth of the cardiac biomarker market.

The upsurge in healthcare expenditures stands as a catalyst for the burgeoning cardiac biomarker market. Health expenditures encompass all costs associated with delivering health services, including cardiac biomarker-related expenses aiming to enhance early detection, personalized treatment, and effective resource allocation for cardiovascular diseases. For example, the Centers for Medicare & Medicaid Services reported a 2.7% increase, totaling $12,914 per person in healthcare spending in the United States in 2021, amounting to $4.3 trillion. Notably, healthcare spending constituted 18.3% of the country's GDP. Thus, the surge in healthcare expenditures significantly drives the expansion of the cardiac biomarker market.

Technological advancements represent a pivotal trend gaining momentum in the cardiac biomarker market. Companies within this sector are actively embracing new technologies to fortify their market positions. For instance, Roche Diagnostics introduced five new solutions utilizing Elecsys technology in April 2021, catering to two vital cardiac biomarkers, highly sensitive cardiac troponin T (cTnT-hs) and the N-terminal pro-brain natriuretic peptide test (NT-proBNP). These solutions aid in cardiac risk identification, improving diagnosis, and facilitating early treatment by identifying cardiovascular risk factors.

Prominent companies in the cardiac biomarker market are dedicated to developing innovative assays to expand their product portfolios, aiming to enhance patient outcomes and address unmet medical needs. These innovative biomarker assays contribute to advancements in cardiac diagnostics, improving accuracy and diagnostic capabilities. For instance, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. launched two new cardiac biomarkers, high-sensitivity troponin I (hs-cTnI) and NT-proBNP. These additions augment Mindray's varied portfolio of cardiac biomarkers, bolstering capabilities in diagnosing and managing cardiovascular diseases (CVDs).

In September 2021, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a China-based leader in medical devices and solutions, completed the acquisition of HyTest Ltd. The acquisition's financial details remain undisclosed. Through this strategic move, Mindray seeks to solidify its standing within the global In-Vitro Diagnostics (IVD) market while extending its reach into Europe and other international markets. Furthermore, the acquisition aims to bolster Mindray's ongoing research and development initiatives, fostering the exploration of novel technologies and fostering collaborations within academic circles. HyTest Ltd., headquartered in Finland, specializes in providing in-vitro diagnostic reagents, particularly excelling in the field of cardiac biomarkers.

Major companies operating in the cardiac biomarkers market report are bioMerieux Inc., Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Siemens AG, Thermo Fisher Scientific Inc., Creative Diagnostics, Randox Laboratories Ltd., Becton Dickinson and Company, Tosoh Corporation, Life Diagnostics, PerkinElmer Inc., Quidel Corporation, ACS Biomarker BV, LSI Medience Corp., BioDot, Alere Inc., Biosensors International Group, Biosynex SA, CardioGenics Holdings Inc., Danaher Corporation, Cortez Diagnostics Inc., DIALAB GmbH, Eurolyser Diagnostica GmbH, Grifols SA, Hologic Inc., InfraRedx Inc., Labcorp Corp., Lepu Medical Technology, Myriad Genetics, Nanosphere Inc., Biora Therapeutics Inc., Quest Diagnostics

North America was the largest region in the cardiac biomarkers market in 2023. The regions covered in the cardiac biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cardiac biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiac biomarkers market consists of sales of assays and reagents, point-of-care testing (POCT) devices, instruments, and software solutions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11596

1. Executive Summary

2. Cardiac Biomarkers Market Characteristics

3. Cardiac Biomarkers Market Trends And Strategies

4. Cardiac Biomarkers Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Cardiac Biomarkers Market Size and Growth

5.1. Global Cardiac Biomarkers Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Cardiac Biomarkers Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Cardiac Biomarkers Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cardiac Biomarkers Market Segmentation

6.1. Global Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Creatine Kinase (CK-Mb)
Troponins
Myoglobin
Natriuretic Peptides (BNP And NT-proBNP)
Ischemia Modified Albumin (IMA)
Other Biomarker Types
6.2. Global Cardiac Biomarkers Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Point Of Care Testing
Laboratory Testing
6.3. Global Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome (ACS)
Atherosclerosis
Other Applications
6.4. Global Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Specialty Clinics

7. Cardiac Biomarkers Market Regional And Country Analysis

7.1. Global Cardiac Biomarkers Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Cardiac Biomarkers Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cardiac Biomarkers Market

8.1. Asia-Pacific Cardiac Biomarkers Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cardiac Biomarkers Market

9.1. China Cardiac Biomarkers Market Overview
9.2. China Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cardiac Biomarkers Market

10.1. India Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cardiac Biomarkers Market

11.1. Japan Cardiac Biomarkers Market Overview
11.2. Japan Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cardiac Biomarkers Market

12.1. Australia Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cardiac Biomarkers Market

13.1. Indonesia Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cardiac Biomarkers Market

14.1. South Korea Cardiac Biomarkers Market Overview
14.2. South Korea Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cardiac Biomarkers Market

15.1. Western Europe Cardiac Biomarkers Market Overview
15.2. Western Europe Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cardiac Biomarkers Market

16.1. UK Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cardiac Biomarkers Market

17.1. Germany Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cardiac Biomarkers Market

18.1. France Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cardiac Biomarkers Market

19.1. Italy Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cardiac Biomarkers Market

20.1. Spain Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cardiac Biomarkers Market

21.1. Eastern Europe Cardiac Biomarkers Market Overview
21.2. Eastern Europe Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cardiac Biomarkers Market

22.1. Russia Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cardiac Biomarkers Market

23.1. North America Cardiac Biomarkers Market Overview
23.2. North America Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cardiac Biomarkers Market

24.1. USA Cardiac Biomarkers Market Overview
24.2. USA Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cardiac Biomarkers Market

25.1. Canada Cardiac Biomarkers Market Overview
25.2. Canada Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cardiac Biomarkers Market

26.1. South America Cardiac Biomarkers Market Overview
26.2. South America Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cardiac Biomarkers Market

27.1. Brazil Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cardiac Biomarkers Market

28.1. Middle East Cardiac Biomarkers Market Overview
28.2. Middle East Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cardiac Biomarkers Market

29.1. Africa Cardiac Biomarkers Market Overview
29.2. Africa Cardiac Biomarkers Market, Segmentation By Biomarkers Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Cardiac Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Cardiac Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cardiac Biomarkers Market Competitive Landscape And Company Profiles

30.1. Cardiac Biomarkers Market Competitive Landscape
30.2. Cardiac Biomarkers Market Company Profiles
- 30.2.1. BioMerieux Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Bio-Rad Laboratories
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. F. Hoffmann-La Roche AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Siemens AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Thermo Fisher Scientific Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Cardiac Biomarkers Market Competitive Benchmarking

32. Global Cardiac Biomarkers Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Cardiac Biomarkers Market

34. Cardiac Biomarkers Market Future Outlook and Potential Analysis

34.1 Cardiac Biomarkers Market In 2028 - Countries Offering Most New Opportunities
34.2 Cardiac Biomarkers Market In 2028 - Segments Offering Most New Opportunities
34.3 Cardiac Biomarkers Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer